# Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia

> **NCT00270530** · PHASE4 · COMPLETED · sponsor: **Center for International Health and Development** · enrollment: 454 (—)

## Conditions studied

- Placental Malaria Infection
- HIV Infections
- Stillbirth
- Prematurity
- Neonatal Deaths

## Interventions

- **DRUG:** Sulfadoxine-pyrimethamine (Fansidar)

## Key facts

- **NCT ID:** NCT00270530
- **Lead sponsor:** Center for International Health and Development
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 454 (—)
- **Last updated:** 2006-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00270530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00270530, "Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00270530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*